RHUDEX

Medigene Limited

Application Filed: 2003-08-11

Trademark Application Details

Status

710

Dead/Cancelled

CANCELLED - SECTION 8

Research	OneLook Acronym Finder
Serial Number	78285532
Registration Number	2943640
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Cancellation Code	2
Domestic Representative	Purvi J. Patel
Attorney Name	Purvi J. Patel
Attorney Docket Number	21573.Avidex
Law Office Assigned	L20
Employee Name	SUAREZ, MARIA VICTORIA

Timeline

2003-08-11	Application Filed
2005-02-01	Published for Opposition
2005-04-26	Location: PUBLICATION AND ISSUE SECTION
2005-04-26	Trademark Registered
2012-09-28	Cancelled
2012-09-28	Status: Dead/Cancelled
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	MEDIGENE LIMITED
Entity Statement	PRIVATE LIMITED COMPANY
Address	57C MILTON PARK MILTON, ABINGDON OXFORDSHIRE GB OX14 4RX
Legal Entity Type
Legal Entity State	GB

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Purvi J. Patel
Haynes and Boone, LLP
2323 Victory Avenue, Suite 700
Dallas TX 75219-7673

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics

Type Code

Type

GS0051

Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	2004-01-24	1 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED	2004-02-03	2 CNRT F:First Action
PAPER RECEIVED	2004-08-05	3 MAIL I:Incoming Correspondence
Sec. 1(B) CLAIM DELETED	2004-08-05	4 1.BD I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-08-05	5 CRFA I:Incoming Correspondence
AMENDMENT FROM APPLICANT ENTERED	2004-08-30	6 ACEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2004-11-21	7 CNSA O:Outgoing Correspondence
ASSIGNED TO LIE	2004-11-29	8 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2004-11-30	9 PREV O:Outgoing Correspondence
NOTICE OF PUBLICATION	2005-01-12	10 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2005-02-01	11 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2005-04-26	12 R.PR A:Allowance for Publication
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2007-09-19	13 ASGN I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2008-12-17	14 TCCA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2008-12-17	15 TCCA I:Incoming Correspondence
CANCELLED SEC. 8 (6-YR)	2012-09-28	16 C8.. O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
RHUDEX 88245830 not registered Live/Pending	Medigene AG 2018-12-31
RHUDEX 85362627 4322812 Dead/Cancelled	Medigene Limited 2011-07-04
RHUDEX 78285532 2943640 Dead/Cancelled	MEDIGENE LIMITED 2003-08-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.